Together for a better
healthcare journey
-
Released “Bringing New Options for Cancer Treatment: Market Development for Cancer Gene Panel Testing” on Our Stories -
Opening Ceremony Held for New Manufacturing Base in India - Digest Video Released - -
Business Results Announcement for the Fiscal Year Ended March 31, 2025 -
Employee Interview Video Series - Our People: Advancing and Supporting the Future of Healthcare -
Released “Development of the World’s First Blood Testing System” on Stories
Story
News
-
InformationSysmex’s Automated Blood Coagulation Analyzer CN™-6000 Receives U.S. FDA 510(k) Clearance
-
Press ReleaseSysmex Completes Subsidiary's New Instrument Manufacturing Factory in Nagano, Japan, and Begins Product Shipments
- Strengthening the Group’s Instrument Production System to Ensure Stable Global Supply and Enhanced Productivity - -
Press ReleaseSummary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (PDF：357KB)
-
Press ReleaseSysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2025 (PDF：130KB)
-
Press ReleaseNotification Regarding Reversal of Deferred Tax Assets (Non-Consolidated Financial Results) (PDF：97KB)
-
Press ReleaseAnnouncement of Executive Changes (PDF：205KB)
-
Press ReleaseAnnouncement Regarding the Introduction of the Performance-Linked Stock Compensation Plan (PDF：216KB)
-
Press ReleaseSysmex and Gaudi Clinical Agree on a Business Collaboration and Capital Alliance
- Aiming to Provide Safer, Higher Quality Treatments in the Field of Regenerative Cellular Medicine -
Topics
-
Released "Bringing New Options for Cancer Treatment: Market Development for Cancer Gene Panel Testing" on Our Stories
-
Business Results Announcement for the Fiscal Year Ended March 31, 2025 (See Latest Financial Statements)
-
Released "Delivering High-Quality Made in Japan Products to the World: Production Transfer Project to India" on Our Stories
Discover Sysmex
